Publications
Filters: Author is Fleming, S [Clear All Filters]
Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney international. 1994;46:1528-32. Abstract
A genetic model of malignant phase hypertension in rats. Kidney international. 1995;47:529-35. Abstract
Targeted inactivation of the Ren-2 gene in mice. Hypertension. 1996;28:1126-31. Abstract
Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. The Journal of biological chemistry. 1997;272:18185-90. Abstract
Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. Journal of hypertension. 1998;16:635-43. Abstract
Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney international. 1999;56:414-20. Abstract
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. The Journal of clinical investigation. 1999;103:683-9. Abstract
Granulation rescue and developmental marking of juxtaglomerular cells using "piggy-BAC" recombination of the mouse ren locus. The Journal of biological chemistry. 2000;275:40378-84. Abstract
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. The Journal of biological chemistry. 2001;276:36727-33. Abstract
Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. Molecular pathology : MP. 2002;55:29-33. Abstract


]